Retatrutide has attracted significant attention due to its unique triple-receptor activity involving GLP-1, GIP, and glucagon receptors
To complicate matters, microdosing programs typically rely on compounded versions of the medication, which carry their own risks
Individual results may vary.
This keeps the conversation grounded in health history, goals, and whether the option is appropriate for the person requesting it
If traditional single-agonist medications haven't met your weight loss expectations, Zepbound is a promising option available at Klinic
By influencing both pathways, Mounjaro may provide additional benefits for blood sugar management and appetite control compared to GLP-1 agonists alone